Article
The Biology of Relapsed Acute Lymphoblastic Leukemia
17 Jun 2014
Abstract excerpt
Although great strides have been made in the improvement of outcome for newly diagnosed pediatric acute lymphoblastic leukemia because of refinements in risk stratification and selective intensification of therapy, the prognosis for relapsed leukemia has lagged behind significantly. Understanding the underlying biological pathways responsible for drug resistance is essential to develop novel approaches for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
